W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

X

News

29 August, 2022
Recommendation of the President – on qualifying selected diagnostic, ultrasound, invasive, electrophysiological, and functional examinations as well as specialist advice and consultations for the list of guaranteed health care services in the scope of primary health care
read more
29 August, 2022
Recommendation of the President – Milupa Basic-P
read more
25 August, 2022
The Meeting of the Transparency Council No. 35/2022 of 05.09.2022
read more
24 August, 2022
The Meeting of the Tariffs Council No. 20/2022 of 25.08.2022 – update
read more
24 August, 2022
Position of the Transparency Council – Milupa Basic-P
read more
24 August, 2022
Position of the Transparency Council – Ospolot (sultiam)
read more
24 August, 2022
Position of the Transparency Council – Jardiance (empagliflozyna)
read more
24 August, 2022
Position of the Transparency Council – Yervoy (ipilimumab)
read more
24 August, 2022
Position of the Transparency Council – Opdivo (niwolumab)
read more
24 August, 2022
Position of the Transparency Council – Tremfya (guselkumabum)
read more
24 August, 2022
Opinion of the Transparency Council – methotrexatum
read more
24 August, 2022
Opinion of the Transparency Council – cyclophosphamidum
read more
24 August, 2022
Opinion of the Transparency Council – azathioprinum
read more
24 August, 2022
Position of the Transparency Council – Empliciti (elotuzumab)
read more
24 August, 2022
Position of the Transparency Council – Ontozry (cenobamat)
read more
24 August, 2022
Opinion of the Transparency Council – recommended medical technologies, actions to be carried out under health policy programmes and the implementation conditions for the glaucoma prevention programmes
read more
24 August, 2022
Position of the Transparency Council – qualifying of health care services financed from the entrusted budget and provided on the order of a primary care physician
read more
24 August, 2022
The Meeting of the Tariffs Council No. 21/2022 of 01.09.2022
read more
22 August, 2022
The Meeting of the Transparency Council No. 34/2022 of 29.08.2022
read more
19 August, 2022
Communication – new tariffs covering neonatal care
read more
18 August, 2022
The Meeting of the Tariffs Council No. 20/2022 of 25.08.2022
read more
18 August, 2022
Recommendation of the President – Rezurock (belumosudil)
read more
17 August, 2022
The Meeting of the Transparency Council No. 33/2022 of 22.08.2022
read more
16 August, 2022
Opinion of the Transparency Council – health policy programme on thyroid diseases (Town of Leszno)
read more

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑